← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2000Last known activity
Dec 31, 2025
Timeline
1920s
- Feb 26, 1924
American Heart Association— Founded
Drugs by trial phase (107 distinct, 98 trials)
Phase 4 (26 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (27 own, 0 via acquisition)
Indications
Studied for
- Abnormalities, Drug-Induced
- Aggression
- Aortic Coarctation
- Apnea
- Atherosclerosis
- Atrial Fibrillation
- Atrial Remodeling
- Bipolar Disorder
- Brain Injuries
- Brain Injuries, Traumatic
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Carotid Stenosis
- Cerebral Hemorrhage
- Cognitive Dysfunction
- Congenital Abnormalities
- Coronary Artery Disease
- Coronary Disease
- Death, Sudden
- Disease
- Heart Arrest
- Heart Defects, Congenital
- Heart Diseases
- Heart Failure
- Heart Failure, Systolic
- Hemorrhage
- Hyperlipidemias
- Hypersensitivity
- Hypertension
- Hypotension
- Infarction
- Inflammation
- Insulin Resistance
- Jervell-Lange Nielsen Syndrome
- Kidney Diseases
- Kidney Failure, Chronic
- Long QT Syndrome
- Metabolic Syndrome
- Multiple Trauma
- Myocardial Infarction
- Myocardial Ischemia
- Obesity
- Out-of-Hospital Cardiac Arrest
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Prediabetic State
- Prehypertension
- Psychotic Disorders
- Recurrence
- Renal Insufficiency, Chronic
- Sarcoidosis
- Schizophrenia
- Shock
- Shock, Septic
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Subarachnoid Hemorrhage
- Syndrome
- Tachycardia
- Torsades de Pointes
- Vasospasm, Intracranial
- Ventricular Fibrillation
- Ventricular Remodeling
- Wounds and Injuries
Recent trials (50)
- NCT06369350CollaboratorEarly Phase 1Dec 31, 2025
- NCT07202000CollaboratorPhase 2Nov 1, 2025
- NCT06921603CollaboratorN/AJun 29, 2025
- NCT06369571CollaboratorPhase 1/Phase 2Oct 4, 2024
- NCT06424834CollaboratorPhase 2/Phase 3Aug 29, 2024
- NCT06195982CollaboratorPhase 2Mar 6, 2024
- NCT06104228CollaboratorPhase 2Jan 1, 2024
- NCT06111768CollaboratorPhase 2Dec 31, 2023
- NCT05844501CollaboratorPhase 4Nov 1, 2023
- NCT06040255CollaboratorPhase 4Oct 1, 2023
- NCT06133634CollaboratorPhase 1/Phase 2Sep 25, 2023
- NCT05256069CollaboratorEarly Phase 1Feb 28, 2023
- NCT05605548CollaboratorN/AJan 31, 2023
- NCT05373108CollaboratorPhase 4May 19, 2022
- NCT05139914CollaboratorPhase 4Jan 31, 2022
Details
- Founded
- Dallas, TX, US Feb 26, 1924
- Last known activity
- Dec 31, 2025